generic glp-1 agonist Article » ProAct Table 1 from Glucagon-Like Peptide-1
Description
Mollan SP, Wakerley BR, Alimajstorovic Z, et al

S.HarveyB

The review found that serious anesthesia risks linked to these drugs are uncommon for most patients and can usually be managed through individualized planning rather than stopping the medication

Ongoing and future largescale randomized trials will be critical for clarifying efficacy and safety for this use
